(Q40708366)

English

Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure

scientific article published on January 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Erjavec Z

1

1 reference

Europe PubMed Central

22 September 2017

de Vries-Hospers HG

2

1 reference

Europe PubMed Central

22 September 2017

van Kamp H

3

1 reference

Europe PubMed Central

22 September 2017

van der Waaij D

4

1 reference

Europe PubMed Central

22 September 2017

Halie MR

5

1 reference

Europe PubMed Central

22 September 2017

Daenen SM

6

1 reference

Europe PubMed Central

22 September 2017

publication date

1 January 1994

1 reference

Europe PubMed Central

22 September 2017

Scandinavian Journal of Infectious Diseases

1 reference

Europe PubMed Central

22 September 2017

26

1 reference

Europe PubMed Central

22 September 2017

585-595

1 reference

Europe PubMed Central

22 September 2017

5

1 reference

Europe PubMed Central

22 September 2017

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Imipenem/cilastatin as initial therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Gram-positive infections in granulocytopenic patients: an important issue?

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Imipenem/Cilastatin

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Imipenem-cilastatin as initial therapy for febrile cancer patients

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

The role of Gram-positive therapy in the neutropenic patient

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

https://api.crossref.org/works/10.3109%2F00365549409011817

21 January 2018

Identifiers

10.3109/00365549409011817

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40708366&oldid=1904983406"